C. Benden (Zürich, Switzerland), R. Vos (Leuven, Belgium)
Influences of primary graft dysfunction (PGD) on parenchymal remodeling after lung transplantation (LT) detected by mean quantitative computed tomography (CT).
C. Salito (Milano, Italy), A. Aliverti (Milano, Italy), D. Tosi (Milano, Italy), F. Pennati (Milano, Italy), R. Carrinola (Milano, Italy), L. Rosso (Milano, Italy), P. Tarsia (Milano, Italy), L. Morlacchi (Milano, Italy), M. Nosotti (Milano, Italy), A. Palleschi (Milano, Italy)
|  |
Diagnosis of antibody-mediated rejection (AMR) on lung transplant biopsies: A retrospective single-center case study
S. Geleff (Vienna, Austria), G. Fischer (Vienna, Austria), P. Jaksch (Vienna, Austria)
|   |
Is influenza trivalent vaccination effective in lung transplant recipients?
L. Khorsheed (Dublin, Ireland), S. Walsh (Dublin, Ireland), P. Ging (Dublin, Ireland), S. Winward (Dublin, Ireland), I. Lawrie (Dublin, Ireland), B. Lynch (Dublin, Ireland), J. Egan (Dublin, Ireland), J. Kleinerova (Dublin, Ireland)
| |
Clinical implications of host-bacteria-virus interactions in lung transplantation
D. Wurlod (Lausanne, Switzerland), E. Bernasconi (Lausanne, Switzerland), C. Pattaroni (Lausanne, Switzerland), J. Aubert (Lausanne, Switzerland), B. Marsland (Lausanne, Switzerland), L. Nicod (Lausanne, Switzerland)
| |
Bronchiectasis as prognostic factor in bronchiolitis obliterans syndrome after lung transplantation
A. Van Herck (Leuven, Belgium), A. Sacreas (Leuven, Belgium), T. Heigl (Leuven, Belgium), S. Verleden (Leuven, Belgium), B. Vanaudenaerde (Leuven, Belgium), W. De Wever (Leuven, Belgium), G. Verleden (Leuven, Belgium), R. Vos (Leuven, Belgium)
| |
The murine orthotopic single lung transplantation model for chronic rejection: work in progress?
T. Heigl (Leuven, Belgium), J. Kaes (Leuven, Belgium), A. Sacreas (Leuven, Belgium), A. Van Herck (Leuven, Belgium), G. Vande Velde (Leuven, Belgium), S. Verleden (Leuven, Belgium), G. Verleden (Leuven, Belgium), W. Janssens (Leuven, Belgium), R. Vos (Leuven, Belgium), B. Vanaudenaerde (Leuven, Belgium)
| |
B cells drive iBALT formation in a mouse model of chronic lung allograft dysfunction
N. Smirnova (Denver, United States of America), T. Conlon (Munich, Germany), C. Morrone (Munich, Germany), A. Yildirim (Munich, Germany), O. Eickelberg (Dever, United States of America)
| |